Ocuphire Pharma Statistics Share Statistics Ocuphire Pharma has 27.13M
shares outstanding. The number of shares has increased by 3.54%
in one year.
Shares Outstanding 27.13M Shares Change (YoY) 3.54% Shares Change (QoQ) 0% Owned by Institutions (%) 38.51% Shares Floating 24.52M Failed to Deliver (FTD) Shares 21,315 FTD / Avg. Volume 15.32%
Short Selling Information The latest short interest is 929.65K, so 0% of the outstanding
shares have been sold short.
Short Interest 929.65K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 12.03
Valuation Ratios The PE ratio is -0.46 and the forward
PE ratio is -3.9.
Ocuphire Pharma's PEG ratio is
0.
PE Ratio -0.46 Forward PE -3.9 PS Ratio 0 Forward PS 0.9 PB Ratio 3.89 P/FCF Ratio -1.02 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Ocuphire Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.24,
with a Debt / Equity ratio of 0.
Current Ratio 3.24 Quick Ratio 3.24 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-4.11M Employee Count 14 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -29.52% in the
last 52 weeks. The beta is 0.31, so Ocuphire Pharma's
price volatility has been higher than the market average.
Beta 0.31 52-Week Price Change -29.52% 50-Day Moving Average 1.23 200-Day Moving Average 1.68 Relative Strength Index (RSI) 37.64 Average Volume (20 Days) 139,151
Income Statement
Revenue n/a Gross Profit -28M Operating Income -62.07M Net Income -57.53M EBITDA -62.07M EBIT n/a Earnings Per Share (EPS) -2.15
Full Income Statement Balance Sheet The company has 30.32M in cash and 0 in
debt, giving a net cash position of 30.32M.
Cash & Cash Equivalents 30.32M Total Debt n/a Net Cash n/a Retained Earnings -139M Total Assets 48.17M Working Capital 23.68M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -25.58M
and capital expenditures 0, giving a free cash flow of -25.58M.
Operating Cash Flow -25.58M Capital Expenditures n/a Free Cash Flow -25.58M FCF Per Share -0.96
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields OCUP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for OCUP is $14,
which is 1096.6% higher than the current price. The consensus rating is "Buy".
Price Target $14 Price Target Difference 1096.6% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 6, 2020. It was a
backward
split with a ratio of 1:4.
Last Split Date Nov 6, 2020 Split Type backward Split Ratio 1:4
Scores Altman Z-Score -7.25 Piotroski F-Score 2
